Debabrata Saha

New strategies for colorectal cancer prevention and treatment.

Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation.

Potential for combined modality therapy of cyclooxygenase inhibitors and radiation.

COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.

Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells.

The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity.

Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells.

The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.

Correlation of HER1/EGFR expression and degree of radiosensitizing effect of the HER1/EGFR-tyrosine kinase inhibitor erlotinib.

SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.

Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.

DNA-PKcs-dependent modulation of cellular radiosensitivity by a selective cyclooxygenase-2 inhibitor.

Sustained metaphase arrest in response to ionizing radiation in a non-small cell lung cancer cell line.

The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.

Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy.

The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.

SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression.

The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.

RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.

Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate.

Mechanisms of resistance to ionizing radiation in rectal cancer.

The 'holi' dermatoses: annual spate of skin diseases following the spring festival in India.

Tissue microarray constructs to predict a response to chemoradiation in rectal cancer.

Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.

Loss of p15/Ink4b accompanies tumorigenesis triggered by complex DNA double-strand breaks.

An orthotopic lung tumor model for image-guided microirradiation in rats.

Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.

Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer.

Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.